← Back to patent-cliff list
[11C]CS1P1
Tier C — Watch / trade[11C]CS1P1
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：S1PR1
Indications (approved)：Brain metastases, 中枢神经系统肿瘤, Alzheimer's disease
Regional status
US
Phase II
2026-04-16
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of [11C]CS1P1?
Approved indications include: Brain metastases, 中枢神经系统肿瘤, Alzheimer's disease.
When does the [11C]CS1P1 patent expire?
No public expiry year is available for [11C]CS1P1 yet; this page updates once verified.
How do I get a quote for [11C]CS1P1 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29